Maze’s current research interests include optimizing transfusion support for patients with hematologic malignancies and management of Myeloproliferative Neoplasms (MPN).She is also interested in pregnancy management in patients with MPN and optimizing patient selection and timing of allogeneic transplantation for myelofibrosis. She is the primary investigator or co-investigator on clinical trials of treatment and supportive care of patients with hematologic malignancies.